First, the ‘extra virgin’ grade measures oxidative damage and freshness, not the bioactive compounds responsible for cardiovascular protection. The International Olive Council’s standards assess free acidity, peroxide value, and sensory characteristics—useful indicators of product stability, but irrelevant to health-promoting potential.
Second, polyphenol content in retail extra virgin olive oil varies dramatically within the same quality tier, ranging from under 10 mg/kg to over 1,700 mg/kg. This 170-fold variation means consumers cannot rely on premium labelling alone. Third, the PREDIMED trial demonstrated that high-polyphenol extra virgin olive oil reduces cardiovascular events by 31%—yet 90–96% of retail stock falls below the polyphenol threshold needed to support such health claims.
The practical takeaway: look beyond the label grade. Until mandatory polyphenol labelling becomes standard, consumers seeking olive oil’s cardiovascular benefits must seek independent testing data or prioritize producers with documented bioactive profiles.
Read the full article on GMJ Newsroom.
Was this article helpful?
